Showing 2 of 2 recruiting trials for “MELAS”
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
A Study to Assess TTI-0102 vs Placebo in MELAS Patients
👨⚕️ Patrice P Rioux, MD, PhD, Thiogenesis Therapeutics, Inc.📍 2 sites📅 Started May 2025View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →